Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate
(23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate (21)
- Information Technology Services Directorate (2)
- Isotope Science and Enrichment Directorate (6)
- National Security Sciences Directorate (17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (128)
- User Facilities (27)
Researcher
- Srikanth Yoginath
- James J Nutaro
- Pratishtha Shukla
- Sudip Seal
- Ali Passian
- Brian Sanders
- Bruce Moyer
- Debjani Pal
- Gerald Tuskan
- Harper Jordan
- Ilenne Del Valle Kessra
- Jeffrey Einkauf
- Jennifer M Pyles
- Jerry Parks
- Joel Asiamah
- Joel Dawson
- Justin Griswold
- Kuntal De
- Laetitia H Delmau
- Luke Sadergaski
- Mike Zach
- Nance Ericson
- Padhraic L Mulligan
- Paul Abraham
- Sandra Davern
- Varisara Tansakul
- Vilmos Kertesz
- Xiaohan Yang
- Yang Liu

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

Digital twins (DTs) have emerged as essential tools for monitoring, predicting, and optimizing physical systems by using real-time data.

Simulation cloning is a technique in which dynamically cloned simulations’ state spaces differ from their parent simulation due to intervening events.

Detection of gene expression in plants is critical for understanding the molecular basis of plant physiology and plant responses to drought, stress, climate change, microbes, insects and other factors.

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.

There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

The invention provides on-line analysis of droplets for mass spectrometry.